Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock Has Consensus Target Price of $100.00 According to Analysts

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) have received an average recommendation of “Moderate Buy” from the twelve research firms that are currently covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $100.00.

A number of research analysts recently commented on MMSI shares. Raymond James Financial reissued an “outperform” rating and issued a $100.00 target price on shares of Merit Medical Systems in a research note on Friday, July 31st. Barrington Research set a $114.00 price target on Merit Medical Systems in a research note on Friday, July 31st. Zacks Research cut Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a report on Monday, October 19th. Robert W. Baird set a $98.00 price objective on Merit Medical Systems in a research report on Friday, July 31st. Finally, Wells Fargo & Company increased their price objective on Merit Medical Systems from $74.00 to $83.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. AMI Asset Management Corp lifted its position in shares of Merit Medical Systems by 0.8% during the first quarter. AMI Asset Management Corp now owns 21,818 shares of the medical instruments supplier’s stock worth $1,504,000 after purchasing an additional 168 shares during the last quarter. Arizona State Retirement System grew its holdings in shares of Merit Medical Systems by 1.1% in the second quarter. Arizona State Retirement System now owns 16,459 shares of the medical instruments supplier’s stock worth $1,141,000 after purchasing an additional 174 shares during the last quarter. Sowell Financial Services LLC grew its holdings in shares of Merit Medical Systems by 4.0% in the third quarter. Sowell Financial Services LLC now owns 4,609 shares of the medical instruments supplier’s stock worth $397,000 after purchasing an additional 179 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in shares of Merit Medical Systems by 16.2% in the first quarter. EverSource Wealth Advisors LLC now owns 1,551 shares of the medical instruments supplier’s stock worth $107,000 after purchasing an additional 216 shares during the last quarter. Finally, Brucke Financial Inc. increased its stake in Merit Medical Systems by 5.8% in the 3rd quarter. Brucke Financial Inc. now owns 4,475 shares of the medical instruments supplier’s stock worth $386,000 after buying an additional 247 shares during the period. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Trading Up 1.0%

Merit Medical Systems stock opened at $94.20 on Thursday. The stock has a market cap of $5.62 billion, a P/E ratio of 25.42, a PEG ratio of 2.33 and a beta of 0.51. Merit Medical Systems has a fifty-two week low of $59.74 and a fifty-two week high of $94.85. The firm’s fifty day moving average price is $88.45 and its 200-day moving average price is $77.08. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.23. The company had revenue of $418.84 million during the quarter, compared to analyst estimates of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%. The firm’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the company earned $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Equities research analysts forecast that Merit Medical Systems will post 3.84 earnings per share for the current fiscal year.

About Merit Medical Systems

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company’s product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.